These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33282857)

  • 1. The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities.
    Rodelo-Haad C; Pendón-Ruiz de Mier MV; Díaz-Tocados JM; Martin-Malo A; Santamaria R; Muñoz-Castañeda JR; Rodríguez M
    Front Cell Dev Biol; 2020; 8():543099. PubMed ID: 33282857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of magnesium in CKD.
    Sakaguchi Y
    Clin Exp Nephrol; 2022 May; 26(5):379-384. PubMed ID: 35076791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection?
    Sakaguchi Y; Hamano T; Isaka Y
    Adv Chronic Kidney Dis; 2018 May; 25(3):274-280. PubMed ID: 29793667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcification: When should we interfere in chronic kidney disease patients and how?
    Sharaf El Din UA; Salem MM; Abdulazim DO
    World J Nephrol; 2016 Sep; 5(5):398-417. PubMed ID: 27648404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Protective Role of Klotho in CKD-Associated Cardiovascular Disease.
    Bi X; Yang K; Zhang B; Zhao J
    Kidney Dis (Basel); 2020 Nov; 6(6):395-406. PubMed ID: 33313060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease⁻Metabolic Bone Disease (CKD-MBD).
    Rodriguez M; Aguilera-Tejero E
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Magnesium, Effects of Hypomagnesemia, and Benefits of Magnesium Supplements in Cardiovascular and Chronic Kidney Diseases.
    Panta R; Regmi S
    Cureus; 2024 Jul; 16(7):e64404. PubMed ID: 39130977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.
    Bressendorff I; Hansen D; Schou M; Kragelund C; Brandi L
    BMJ Open; 2017 Jun; 7(6):e016795. PubMed ID: 28645983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms.
    Ruiz-Andres O; Sanchez-Niño MD; Moreno JA; Ruiz-Ortega M; Ramos AM; Sanz AB; Ortiz A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1329-F1340. PubMed ID: 27760772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium: An old player revisited in the context of CKD-MBD.
    Pendón-Ruiz de Mier MV; Rodelo-Haad C; Díaz-Tocados JM; Muñoz-Castañeda JR; Rodríguez M
    Clin Chim Acta; 2020 Feb; 501():53-59. PubMed ID: 31836501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
    Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J
    J Nephrol; 2019 Oct; 32(5):791-802. PubMed ID: 30888644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human.
    Liu Q; Zhu LJ; Waaga-Gasser AM; Ding Y; Cao M; Jadhav SJ; Kirollos S; Shekar PS; Padera RF; Chang YC; Xu X; Zeisberg EM; Charytan DM; Hsiao LL
    J Mol Cell Cardiol; 2019 Nov; 136():113-124. PubMed ID: 31520610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin downregulates Klotho in tubular cells.
    Fernandez-Fernandez B; Izquierdo MC; Valiño-Rivas L; Nastou D; Sanz AB; Ortiz A; Sanchez-Niño MD
    Nephrol Dial Transplant; 2018 Oct; 33(10):1712-1722. PubMed ID: 29425318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnesium disorder and its clinical significance in chronic kidney disease].
    Okuno S
    Clin Calcium; 2012 Aug; 22(8):1243-9. PubMed ID: 22846361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the Mechanisms of Magnesium Supplementation in Alleviating Chronic Kidney Disease Complications and Progression: Balancing Risks and Benefits.
    Sadeghpour M; Bejani A; Kupaei MH; Majd SJA; Najafi A; Fakhari S; Abdolizadeh A; Mohammadi K
    Biol Trace Elem Res; 2024 Sep; ():. PubMed ID: 39256329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New markers of cardio-renal links in chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.